The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported pericardial effusion could not be determined.The cause of the reported perforation (atrial: no treatment) associated with the atrial septal defect (asd) could not be determined.The reported patient effects of pericardial effusion and perforation, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
This is filed to report atrial perforation and pericardial effusion requiring intervention.It was reported that a mitraclip procedure was performed to treat degenerative mitral regurgitation (mr) grade 4.A mitraclip was implanted successfully.Then a second xtw mitraclip was positioned on the valve.At that point, a pericardial effusion was noted.It was decided to go ahead with deployment, and the mr was reduced to grade 1.After removal of the steerable guide catheter (sgc), an atrial septal defect (asd) was observed.No treatment was performed for the asd.The patient underwent pericardiocentesis to drain the effusion.No additional information was provided.
|